Evolution of skeletal muscle mass (SMM) during palliative systemic treatment in metastatic colorectal cancer (mCRC) patients participating in the randomized phase 3 CAIRO3 study

Authors :: Sophie A Kurk
Hugo J. Kuijf
Miriam Koopman
A. M. May
Marion Jourdan
P. H. M. Peeters
C.J.A. Punt
Bram Dorresteijn
Oncology
CCA - Cancer Treatment and Quality of Life
Source :: Annals of oncology, 27. Oxford University Press
Publication Year :: 2016
Publisher :: Elsevier BV, 2016.

Subjects :: Oncology
medicine.medical_specialty
Colorectal cancer
business.industry
Internal medicine
medicine
Hematology
Skeletal muscle mass
medicine.disease
business

Full Text Access

Tools